Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients.

MLA

Walsh, Mairéad, et al. “Innate-like T Cell Profile in Myeloma: Severe Deficiency of Vγ9Vδ2 T Cells in Aminobisphosphonate-Treated Patients.” Leukemia & Lymphoma, vol. 57, no. 4, 2016, pp. 977–80. EBSCOhost, https://doi.org/10.3109/10428194.2015.1088653.

APA

Walsh, M., White, G., Romeril, K., Buyck, H., Stephens, M., Brooks, C., & Weinkove, R. (2016). Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients. Leukemia & Lymphoma, 57(4), 977–980. https://doi.org/10.3109/10428194.2015.1088653

Chicago

Walsh, Mairéad, Glennis White, Kenneth Romeril, Huib Buyck, Matthew Stephens, Collin Brooks, and Robert Weinkove. 2016. “Innate-like T Cell Profile in Myeloma: Severe Deficiency of Vγ9Vδ2 T Cells in Aminobisphosphonate-Treated Patients.” Leukemia & Lymphoma 57 (4): 977–80. doi:10.3109/10428194.2015.1088653.